Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients. [electronic resource]
Producer: 20131104Description: 1381-92 p. digitalISSN:- 1432-0851
- Aged
- Antigens, Neoplasm -- genetics
- B-Cell Maturation Antigen -- genetics
- CD3 Complex -- immunology
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cancer Vaccines -- immunology
- Combined Modality Therapy
- Dendritic Cells -- cytology
- Female
- Hemocyanins -- immunology
- Humans
- Immunotherapy, Adoptive -- methods
- Inhibitor of Apoptosis Proteins -- genetics
- Male
- Middle Aged
- Monitoring, Immunologic
- Multiple Myeloma -- immunology
- Neoplasm Proteins -- genetics
- Neoplasm, Residual -- immunology
- RNA, Messenger -- genetics
- Stem Cell Transplantation -- methods
- Survivin
- Transplantation, Autologous
- Treatment Outcome
- Vaccination -- methods
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.